Vancouver, British Columbia, March 23, 2021 (GLOBE NEWSWIRE) -- The global in-situ hybridization market size reached USD 905.3 Million in 2020 and is expected to register a CAGR of 7.1% during the forecast period, according to latest analysis by Emergen Research. The global in-situ hybridization market revenue is expected to grow significantly during the forecast period due to increasing technological advancement such as cytogenetic techniques in the field of in-situ hybridization. Increasing awareness among people regarding availability of tissue diagnostic tests and about ISH techniques is expected to foster in-situ hybridization market growth. Increasing discovery of new therapeutic agents resulting in rising adoption of companion diagnostics is expected to augment global in-situ hybridization market growth during the forecast period.
However, complex procedures involved in in-situ hybridization and difficulty quantifying hybridization result is a key factor expected to hamper market growth to a certain extent over the forecast period.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/584
Some Key Highlights in the Report
- Rising use of chromogenic in-situ hybridization technology in diagnostic laboratories for identification of chromosome number, chromosome translocation, gene deletion, gene amplification is driving revenue growth of the chromogenic in-situ hybridization segment over the forecast period, which is expected to grow at a significant CAGR.
- The infectious diseases segment is expected to register significant growth in terms of share over the forecast period owing to implementation of FISH technique for the treatment of various infectious diseases such as respiratory infections, gastrointestinal infections among others.
- Asia Pacific is expected to register fastest revenue growth rate during the forecast period due to increasing prevalence of cancer and other chronic diseases, rising health care expenditure, and growing demand for quality medical care in countries in the region.
- Key players in the market include Thermo Fisher Scientific, Biocare Medical, Agilent Technologies, Abbott Laboratories, Abnova Corporation, F.Hoffmann-La Roche Ltd.,
Merck KGAa, Danaher Corporation, Bio SB, and BioGenex Laboratories.
- In January 2021, BioCare Medical launched three novel antibody markers to aid pathologists in critical diagnostic decisions. The launch of three markers will help diagnostic centers to provide patients more effective treatment.
Check Our Prices@ https://www.emergenresearch.com/select-license/584
Emergen Research has segmented the global in-situ hybridization market on the basis of technology, application, product type, end-use, and region:
- Technology Outlook (Revenue, USD Million; 2018–2028)
- Fluorescence In-Situ Hybridization (FISH)
- Chromogenic In-Situ Hybridization (CISH)
- Application Outlook (Revenue, USD Million; 2018–2028)
- Cancer Diagnostic
- Infectious Disease
- Immunology
- Neuroscience
- Cytology
- Others
- Product Type Outlook (Revenue, USD Million; 2018–2028)
- Kits & Reagents
- Probes
- Instruments
- Software
- Others
- End-use Outlook (Revenue, USD Million; 2018–2028)
- Diagnostics Laboratories and Hospitals
- Pharmaceutical & Bio-technology
- Academic & Research Institute
- Contract Research Organizations (CRO)
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/in-situ-hybridization-market
- Regional Outlook (Revenue, USD Million; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- BENELUX
- Switzerland
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- Rest of MEA
- North America
Take a Look at our Related Reports:
Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions
Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region
Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region
Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027
Ambulatory EHR Market By Deployment (Cloud-based, On-premises), By Practice Size (Solo Practices, Large Practices, Small-medium-sized Practices), By Application, By End-use (Independent Centers, Hospital-owned Ambulatory Centers, Others), and By Region, Forecasts to 2027
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs
Read Full Press Release: https://www.emergenresearch.com/press-release/global-in-situ-hybridization-market